ArticlePloS one2025
Study on the effect of modified Liu-an decoction on Th1/Th2 function in Guinea pigs with cough variant asthma through the Notch signal pathway.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the effects and mechanism of Modified Liu-an Decoction (MLAD) on Th1/Th2 function and the Notch signaling pathway in guinea pigs with cough variant asthma (CVA).
methods60 SPF Hartley guinea pigs were randomized into six groups (n = 10): the blank control group, model group, montelukast sodium group (MS group), as well as MLAD group of low-dose, mid-dose and high-dose. Intraperitoneal injection of ovalbumin, aluminum hydroxide sensitization, and nebulized inhalation of ovalbumin were performed in all guinea pigs of non-blank control groupto induce CVA. Cough frequency and airway resistance were recorded. The chronic inflammatory infiltration in the airways was detected by using HE and Masson staining smears. The IL-2, IL-4, IL-12, and IL-13 levels were measured by enzyme-linked immunoassay (ELISA). The expression of Delta, Jagged1, Notch1, and NICD proteins in the lung tissues were analyzed by Western blot.
resultsIn terms of airway sensitivity, coughing time and airway resistance were reduced in the MLAD and MS groups compared to the model group (P < 0.05). MLAD reduced the inflammatory infiltration in the lungs of CVA guinea pigs compared with the model group (P < 0.05).For cytokines in BALF, the contents of IL-2 and IL-12 were increased in the MS group and each dose group of MLAD compared with the model group, and the contents of IL-4 and IL-13 were decreased compared with them.The contents of IL-12 were significantly different in each dose group of MLAD compared with the model group; the contents of IL-2 and IL-4 differed with increasing concentrations of MLAD. 4 content with increasing MLAD concentration, the more significant difference. IL-13 content decreased significantly in the MLAD low dose group compared with the model group (P < 0.05). In the serum cytokine model group IL-2, IL-12, IL-13 content were significantly higher than the blank group, IL-4 content was lower than the blank group, and the difference between each intervention group and the model group was not regular. The expression levels of Jagged1, Notch, and NICD proteins in the CVA guinea pigs in the MS group and the low-dose MLAD group were decreased compared with those in the model group, and the expression of Delta1 protein was increased compared with that in the model group (P < 0.05).
conclusionThe addition of Liuan Decoction to the lungs can clear lungs and remove heat and strengthen the spleen to resolve phlegm, congestion, edema degree, reduce airway inflammation, and at the same time can reduce peri-tracheal collagen deposition, effectively improve airway remodeling, by regulating the dynamic balance of Th1/Th2. The specific downstream regulatory mechanisms of Notch signaling pathway need to be explored in further studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.